Changing the standard of care for treating melanoma brain metastases
- PMID: 29602645
- DOI: 10.1016/S1470-2045(18)30187-6
Changing the standard of care for treating melanoma brain metastases
Comment on
-
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27. Lancet Oncol. 2018. PMID: 29602646 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
